MedTrace Logo

Histoblood Group Antigens as a Risk Factor of Asthma

NCT00201266 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2026-03-09

No results posted yet for this study

Summary

This study will evaluate the link between blood group antigens and asthma exacerbations.

Conditions

Interventions

PROCEDURE

Screening

Characterization tests including blood group typing, measures of lung function, measures of allergy, and collection of DNA.

Sponsors & Collaborators

Principal Investigators

  • John V. Fahy · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2011-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00201266 on ClinicalTrials.gov